Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-19-027768

EVP, Chief Technology Officer sold 657 shares at $133.73 ($87,861)

  • EVP, Chief Technology Officer acquired 832 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolorforosh Said EVP, Chief Technology Officer 2019-08-30 Option exercise +832 $93.52 $77,809 2,973 D
Bolorforosh Said EVP, Chief Technology Officer 2019-08-30 Sale −657 $133.73 $87,861 2,316 D
Derivatives
Bolorforosh Said EVP, Chief Technology Officer 2019-08-30 Option exercise · Non-qualified Stock Option (Right to Buy) −832 2,498 D
Open-market sales · 657 sh · avg $133.73 · $87,861
Loading xslF345X03/form4.xml…